$233.49
+11.33 (+5.10%)
At Close: Jun 03, 2026
Axsome Therapeutics Announces Plans to Resubmit AXS-07 NDA Based on Successful FDA Type A Meeting
11:28am, Thursday, 29'th Sep 2022 GlobeNewswire Inc.
NEW YORK, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous sys
2 No-Brainer Biotech Stocks to Buy Right Now
01:53pm, Monday, 26'th Sep 2022 The Motley Fool
If one can bear the risk with these stocks, the rewards can be extraordinary.
3 Monster Stocks in the Making
10:14am, Saturday, 24'th Sep 2022 The Motley Fool
These companies are small now. But they have massive long-term growth prospects.
3 Monster Stocks in the Making
06:14am, Saturday, 24'th Sep 2022
These companies are small now. But they have massive long-term growth prospects.
If You Invested $10,000 in Axsome Therapeutics 5 Years Ago, This Is How Much You Would Have Today
10:50am, Friday, 23'rd Sep 2022 The Motley Fool
Is it too late to invest in this biotech?
2 Reasons to Buy Axsome Therapeutics, and 1 Reason to Sell
10:30am, Thursday, 22'nd Sep 2022 The Motley Fool
Axsome just won approval of a potential blockbuster.
Axsome Therapeutics to Present at the Ladenburg Thalmann Healthcare Conference
07:00am, Wednesday, 21'st Sep 2022
NEW YORK, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous syste
2 Biotech Stocks That Could Make You Richer
02:07pm, Saturday, 17'th Sep 2022 The Motley Fool
Both have performed better than the broader market this year, but one stands out in this category.
Is It Too Late to Buy Axsome Therapeutics Stock?
10:30am, Saturday, 17'th Sep 2022 The Motley Fool
The company's revenue story is just starting.
2 Biotech Stocks That Could Make You Richer
10:07am, Saturday, 17'th Sep 2022
Both have performed better than the broader market this year, but one stands out in this category.
Is It Too Late to Buy Axsome Therapeutics Stock?
06:30am, Saturday, 17'th Sep 2022
The company's revenue story is just starting.
Axsome: In The Middle Of Uncertainty Is Your Biggest Opportunity
01:31pm, Friday, 16'th Sep 2022
For over a year, Axsome Therapeutics suffered substantial share price depreciation due to the uncertain fate of its lead medicine (AXS05). Like the cream that always rises to the top, AXS05 recently g
7 Top-Rated Biotech Stocks to Buy for Q4
03:00pm, Thursday, 15'th Sep 2022
A new White House program will likely boost the entire biotech industry. And it makes these seven names some outstanding biotech stocks to buy for the fourth quarter.
3 Top Healthcare Stocks Defying the Bear Market
10:00am, Thursday, 15'th Sep 2022 The Motley Fool
There's reason to favor these stocks -- and hold on for the long term.
3 Top Healthcare Stocks Defying the Bear Market
06:00am, Thursday, 15'th Sep 2022
There's reason to favor these stocks -- and hold on for the long term.
Sign In
Buy AXSM